Company intelligence / Profile preview

Sapient Laboratories

New Delhi, Delhi, Indiasapientlaboratories.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Sapient Laboratories is an Indian pharmaceutical manufacturer specializing in eye (ophthalmic) and ENT medicines, with a commercial-stage portfolio spanning eye drops, syrups, tablets, ointments, and capsules used for anti-infective, anti-allergic, anti-inflammatory and other therapeutic purposes[2][3][9].

Therapeutic areas
OphthalmologyOther
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

2 assets

Diflusap

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Sapient Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sapient Laboratories.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call